Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hartman

Showing results (351-360 of 459) with videos related to

Pageof 46
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 8, 2009
Pyridine containing M(1) positive allosteric modulators with reduced plasma protein bindingScott D Kuduk, Christina N Di Marco, Victoria Cofre, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongationJ J Cook, G R Sitko, M A Holahan, et al.
Circulation|August 5, 1997
Nonpeptide glycoprotein IIb/IIIa inhibitors: 14: oral antithrombotic efficacy of L-738,167 in a conscious canine model of coronary artery electrolytic injuryJ J Cook, J D Glass, G R Sitko, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Kinesin spindle protein (KSP) inhibitors. Part 1: The discovery of 3,5-diaryl-4,5-dihydropyrazoles as potent and selective inhibitors of the mitotic kinesin KSPChristopher D Cox, Michael J Breslin, Brenda J Mariano, et al.
Leukemia|May 3, 2002
Role for c-jun N-terminal kinase in treatment-refractory acute myeloid leukemia (AML): signaling to multidrug-efflux and hyperproliferationL D Cripe, V M Gelfanov, E A Smith, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 1999
Nonpeptide glycoprotein IIB/IIIA inhibitors. 19. A new design paradigm employing linearly minimized, centrally constrained, exosite inhibitorsG D Hartman, M E Duggan, W F Hoffman, et al.
Clinical & Experimental Metastasis|June 26, 2012
The efficacy of Tilmanocept in sentinel lymph mode mapping and identification in breast cancer patients: a comparative review and meta-analysis of the ⁹⁹mTc-labeled nanocolloid human serum albumin standard of careChristopher A Tokin, Frederick O Cope, Wendy L Metz, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2011
High concentration electrophysiology-based fragment screen: discovery of novel acid-sensing ion channel 3 (ASIC3) inhibitorsScott E Wolkenberg, Zhijian Zhao, James J Mulhearn, et al.
Elife|August 27, 2021
NHR-8 and P-glycoproteins uncouple xenobiotic resistance from longevity in chemosensory <i>C. elegans</i> mutantsGabriel A Guerrero, Maxime J Derisbourg, Felix Amc Mayr, et al.
Journal of the American Chemical Society|August 28, 2014
Dipole-mediated rectification of intramolecular photoinduced charge separation and charge recombinationDuoduo Bao, Srigokul Upadhyayula, Jillian M Larsen, et al.
Pageof 46

Showing results (351-360 of 459) with videos related to

Sort By:
Pageof 46
Bioorganic & Medicinal Chemistry Letters|December 8, 2009
Pyridine containing M(1) positive allosteric modulators with reduced plasma protein bindingScott D Kuduk, Christina N Di Marco, Victoria Cofre, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongationJ J Cook, G R Sitko, M A Holahan, et al.
Circulation|August 5, 1997
Nonpeptide glycoprotein IIb/IIIa inhibitors: 14: oral antithrombotic efficacy of L-738,167 in a conscious canine model of coronary artery electrolytic injuryJ J Cook, J D Glass, G R Sitko, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Kinesin spindle protein (KSP) inhibitors. Part 1: The discovery of 3,5-diaryl-4,5-dihydropyrazoles as potent and selective inhibitors of the mitotic kinesin KSPChristopher D Cox, Michael J Breslin, Brenda J Mariano, et al.
Leukemia|May 3, 2002
Role for c-jun N-terminal kinase in treatment-refractory acute myeloid leukemia (AML): signaling to multidrug-efflux and hyperproliferationL D Cripe, V M Gelfanov, E A Smith, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 1999
Nonpeptide glycoprotein IIB/IIIA inhibitors. 19. A new design paradigm employing linearly minimized, centrally constrained, exosite inhibitorsG D Hartman, M E Duggan, W F Hoffman, et al.
Clinical & Experimental Metastasis|June 26, 2012
The efficacy of Tilmanocept in sentinel lymph mode mapping and identification in breast cancer patients: a comparative review and meta-analysis of the ⁹⁹mTc-labeled nanocolloid human serum albumin standard of careChristopher A Tokin, Frederick O Cope, Wendy L Metz, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2011
High concentration electrophysiology-based fragment screen: discovery of novel acid-sensing ion channel 3 (ASIC3) inhibitorsScott E Wolkenberg, Zhijian Zhao, James J Mulhearn, et al.
Elife|August 27, 2021
NHR-8 and P-glycoproteins uncouple xenobiotic resistance from longevity in chemosensory <i>C. elegans</i> mutantsGabriel A Guerrero, Maxime J Derisbourg, Felix Amc Mayr, et al.
Journal of the American Chemical Society|August 28, 2014
Dipole-mediated rectification of intramolecular photoinduced charge separation and charge recombinationDuoduo Bao, Srigokul Upadhyayula, Jillian M Larsen, et al.
Pageof 46